The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Amlodipine Pinewood 10 mg tablets

10 milligram(s) Tablet

Pinewood Laboratories Ltd,PA0281/165/002

Main Information

Trade NameAmlodipine Pinewood 10 mg tablets
Active SubstancesAmlodipine besylate
Strength10 milligram(s)
Dosage FormTablet
Licence HolderPinewood Laboratories Ltd,
Licence NumberPA0281/165/002

Group Information

ATC CodeC08CA Dihydropyridine derivatives
C08CA01 amlodipine


Licence Issued22/02/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back